171 related articles for article (PubMed ID: 2866078)
21. Histamine2-receptor antagonists in gastroduodenal ulcer haemorrhage.
Falk A; Darle N; Haglund U; Törnqvist A
Scand J Gastroenterol Suppl; 1985; 110():95-100. PubMed ID: 2862700
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
[TBL] [Abstract][Full Text] [Related]
23. Optimal therapy for stress gastritis.
Maier RV; Mitchell D; Gentilello L
Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901
[TBL] [Abstract][Full Text] [Related]
24. Use of continuous infusion of histamine2-receptor antagonists in critically ill patients.
Siepler JK; Trudeau W; Petty DE
DICP; 1989 Oct; 23(10 Suppl):S40-3. PubMed ID: 2573209
[TBL] [Abstract][Full Text] [Related]
25. Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury.
McElwee HP; Sirinek KR; Levine BA
Surgery; 1979 Oct; 86(4):620-6. PubMed ID: 483170
[TBL] [Abstract][Full Text] [Related]
26. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
27. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.
Driks MR; Craven DE; Celli BR; Manning M; Burke RA; Garvin GM; Kunches LM; Farber HW; Wedel SA; McCabe WR
N Engl J Med; 1987 Nov; 317(22):1376-82. PubMed ID: 2891032
[TBL] [Abstract][Full Text] [Related]
28. Effects of cimetidine upon gastric secretion and mucosal blood flow in the rat stressed by restraint. A dose-response and prophylaxis trial.
Hemmer J; Schwille PO; Schellerer W; Hofmann W
Res Exp Med (Berl); 1980; 176(3):207-17. PubMed ID: 6102785
[TBL] [Abstract][Full Text] [Related]
29. Moderate reduction of gastric acid secretion in the treatment of peptic ulcer disease.
Jaup BH
Scand J Gastroenterol Suppl; 1985; 111():36-40. PubMed ID: 2861651
[TBL] [Abstract][Full Text] [Related]
30. [Mechanical ventilation-associated pneumonia and the prevention of stress ulcer. A randomized clinical trial of antacids and ranitidine versus sucralfate].
Sirvent JM; Verdaguer R; Ferrer MJ; Avila FJ; Díaz-Prieto A; Carratalá J
Med Clin (Barc); 1994 Mar; 102(11):407-11. PubMed ID: 8182996
[TBL] [Abstract][Full Text] [Related]
31. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
Alekseenko SA; Timoshin SS
Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
[TBL] [Abstract][Full Text] [Related]
32. Ulcer disease of the upper gastrointestinal tract.
Meeroff JC
Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
[No Abstract] [Full Text] [Related]
33. [Prevention of stress ulcer hemorrhage with H2-receptor blockade].
Dammann HG; Müller P; Flasshoff D; Simon B
Med Klin Prax; 1982 Feb; 77(4):54-5. PubMed ID: 6123068
[TBL] [Abstract][Full Text] [Related]
34. Current guidelines on stress ulcer prophylaxis.
Tryba M; Cook D
Drugs; 1997 Oct; 54(4):581-96. PubMed ID: 9339962
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic prophylaxis and treatment of stress ulcers in critically ill patients.
Flannery J; Tucker DA
Crit Care Nurs Clin North Am; 2002 Mar; 14(1):39-51. PubMed ID: 11939644
[TBL] [Abstract][Full Text] [Related]
36. Intragastric pH monitoring.
Driscoll DM; Cioffi WG; Molter NC; McManus WF; Mason AD; Pruitt BA
J Burn Care Rehabil; 1993; 14(5):517-24. PubMed ID: 8245105
[TBL] [Abstract][Full Text] [Related]
37. [Stress ulcerations: pathogenesis and prevention].
Holtermüller KH; Ebener B; Kühl HJ; Rolfs A
Z Gastroenterol; 1983 Mar; 21 Suppl():88-100. PubMed ID: 6134406
[TBL] [Abstract][Full Text] [Related]
38. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
Simon B; Müller P; Dammann HG
Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of intragastric pH in acutely ill patients.
Herrmann V; Kaminski DL
Arch Surg; 1979 Apr; 114(4):511-4. PubMed ID: 35135
[TBL] [Abstract][Full Text] [Related]
40. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
